Liang Liu

Macau, China

Liang Liu

wikipedia

This inventor holds 45 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Cancer Treatment. Top assignees: Macau University of Science and Technology, Hong Kong Baptist University, Everite Consultants Ltd.. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liang Liu. Retrieved from https://idiyas.com/inventor/liang-liu-uglrcm37

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 45 

% Patents Active = 80.0


Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Hong Kong, CN (2008 - 2013)
  • MO, MO (2016)
  • Macao, MO (2017 - 2018)
  • Taipa, CN (2017 - 2019)
  • Taipa, MO (2018 - 2020)
  • Macau, CN (2015 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Glycan Biomarkers
Neurodegenerative Diseases
ALK Kinase Inhibitor
Lung Cancer
Multidrug-Resistant Cancer
AMPK Activators
Triterpenoid
Ginsenoside Derivatives
Prenylated Isoflavones
ROS1 Inhibitor
Lignanamides
Autophagic Enhancers
45 patents (USPTO):Explore Patents

Title: **Liang Liu: Innovator in Biomarkers and Genetic Research**

Introduction

Liang Liu is a prominent inventor based in Macau, China, with an impressive portfolio of 45 patents. His work primarily focuses on the innovative applications of glycan biomarkers in detecting autoimmune diseases and identifying genes associated with various diseases.

Latest Patents

Among his latest patents, one invention presents a groundbreaking method for determining the presence of autoimmune diseases using glycan biomarkers. This invention not only reveals the potential of glycans in disease diagnostics but also discloses a method for enhancing the detection sensitivity of trace glycans using a specialized microfluidic chip. Another notable patent from Liu addresses the identification of genes associated with certain diseases or pathological conditions. This comprehensive method involves comparing exome sequences from different populations to identify variants in genetic data, followed by meticulous filtering to isolate deleterious variants for further analysis.

Career Highlights

Liang Liu has built a strong career in the field of biomedical research and innovation. He has contributed significantly to the academic and scientific communities through his work at esteemed institutions such as the Macau University of Science and Technology and Hong Kong Baptist University. His research endeavors have led to advancements in understanding autoimmune diseases and genetic disorders.

Collaborations

Throughout his professional journey, Liu has collaborated with notable colleagues, including Kam Wai Wong and Yuen Kwan Law. These partnerships have fueled collaborative research initiatives, enhancing the impact of his innovations in the field.

Conclusion

Liang Liu stands out as a visionary inventor, contributing valuable insights and innovations to medical research. His work in using glycan biomarkers for disease detection and genetic analysis not only reflects his expertise but also promises to pave the way for future advancements in the medical field. With his continued pursuit of innovation, Liu is sure to leave a lasting mark on the world of biomedical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…